Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-27

Clinical Trial Update: Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating the tumor microenvironment in invasive, node-positive breast cancer using the Ga-68 labeled FAPi-46 PET/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 68Ga-FAPI-46 (Gallium-68-labeled FAPI-46)

Snippet

Sponsor: European Institute of Oncology | Conditions: Breast Cancer Invasive, Node Positive Breast Cancer | NA | Status: RECRUITING